Melvin K. Spigelman

Melvin K. Spigelman is a declared insider at 2 companies; the most frequent names are Medicines Co /DE and Synergy Pharmaceuticals, Inc. In total, 20 filings cover trades dated from 24 May 2007 to 15 August 2018.

No open-market purchase appears, only 3 sales worth €1.4M. Outside the open market, there are 12 share grants and 5 option exercises. In 2018 alone, the filings show no purchases and 1 sale.

The latest filing, published on 16 August 2018, reports an option exercise of €159k in Synergy Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.